Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 39.83 |
| PEG Ratio (TTM) | N/A | 1.34 |
| P/S Ratio (TTM) | N/A | 3.88 |
| P/B Ratio (TTM) | N/A | 3.27 |
| P/FCF Ratio (TTM) | 0.01 | -33.03 |
| Price to 5YR AVG Earnings Ratio | N/A | 52.78 |
| Price to 5YR AVG FCF Ratio | 0.07 | 38.72 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 1.42% |
| ROE (TTM) | N/A | 442.86% |
| Net Profit Margin (TTM) | N/A | 2.29% |
| ROIC 5YR AVG | N/A | 1.91% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | N/A | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | N/A | N/A | N/A |
| Cash Flow | 296.37% | N/A | N/A |
Health (30%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.49 | 4.09 |
| Quick Ratio (TTM) | 2.49 | 4.08 |
| D/E Ratio (TTM) | N/A | 1.08 |
| Interest Coverage (TTM) | N/A | 5.18 |
| Piotroski F-Score | 5 | 5 |
| Altman Z-Score | 0.10 | 4.41 |
| LTL to 5YR AVG FCF | N/A | 58.84 |
| Shares Outstanding Growth 5YR AVG | N/A | 26.81% |